Abstract
P-23 Clinical outcomes of encorafenib, binimetinib, and cetuximab for pretreated BRAF V600E-mutant metastatic colorectal cancer in the BEACON EAP follow-up study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have